Retrospective Evaluation of Primary Mediastinal Large B Cell Lymphoma Treatment Results

Abstract

Objective: Primary mediastinal large B cell lymphomas (PMLBCL) are aggressive, rare lymphomas known to originate from the thymus medullary B cells. In PMLBCL, which accounts for about 2% of non-Hodgkin’s lymphomas, the referral is usually due to bulky disease. This study summarizes the characteristics, prognosis and survivals of PMLBCL patients with diagnosed and treated in our clinic. Erden AtİllA1,2, Pınar AtAcA AtİllA1,2, Güldane cEnGİz SEvAl1, Selami Koçak toPrAK1, osman İlhAn1, Önder ArSlAn1, Günhan GürmAn1, taner DEmİrEr1, muhit ÖzcAn1 1 Ankara Üniversitesi Tıp Fakültesi, Hematoloji Bilim Dalı, Ankara, Türkiye 2 Baylor College of Medicine, Center for Gene and Cell Therapy, Houston, TX, ABD Uzm. Dr. Erden AtİllA Ankara Üniversitesi Tıp Fakültesi, Hematoloji Bilim Dalı, Ankara-Türkiye Geliş: 10.09.2018 Kabul: 26.09.2018 E-posta: erdenatilla@gmail.com Yazışma Adresi ARAŞTIRMA LLM Dergi 2018;2(3):60-64 • 10.5578/llm.66467